Skip to main content
. 2022 Mar 18;22:115. doi: 10.1186/s12872-022-02559-z

Table 5.

The association between three NPAR groups and 180-day all-cause mortality in subgroup analysis

N NPAR < 21.58
(reference)
21.58 ≤ NPAR < 26.77
HR (95% CIs)
NPAR ≥ 26.77
HR (95% CIs)
p for interaction
AF 0.4736
No 551 1.0 1.42 (0.90, 2.23) 2.80 (1.85, 4.26)
Yes 247 1.0 1.55 (0.86, 2.81) 2.19 (1.26, 3.82)
CHF 0.1939
No 422 1.0 1.18 (0.68, 2.07) 2.89 (1.79, 4.67)
Yes 376 1.0 1.60 (0.99, 2.59) 2.30 (1.45, 3.65)
CKD 0.5369
No 690 1.0 1.54 (1.04, 2.27) 2.53 (1.76, 3.64)
Yes 108 1.0 1.21 (0.47, 3.13) 3.12 (1.35, 7.22)
COPD 0.9520
No 784 1.0 1.50 (1.04, 2.16) 2.62 (1.87, 3.67)
Yes 14 1.0 2.42 (0.15, 39.05) 3.37 (0.40, 28.33)
CAD 0.8694
No 253 1.0 1.72 (0.92, 3.23) 2.54 (1.48, 4.36)
Yes 545 1.0 1.45 (0.94, 2.26) 2.49 (1.61, 3.83)
Hypertension 0.3855
No 453 1.0 1.19 (0.74, 1.91) 2.34 (1.54, 3.55)
Yes 345 1.0 1.95 (1.11, 3.41) 2.86 (1.64, 4.98)
Diabetes 0.3603
No 567 1.0 1.36 (0.90, 2.06) 2.32 (1.58, 3.40)
Yes 231 1.0 1.99 (0.96, 4.13) 3.91 (1.99, 7.70)
Prior MI 0.4050
No 752 1.0 1.54 (1.06, 2.25) 2.84 (2.01, 4.02)
Yes 46 1.0 1.09 (0.33, 3.57) 1.20 (0.35, 4.13)
Stroke 0.4004
No 768 1.0 1.52 (1.05, 2.20) 2.75 (1.95, 3.88)
Yes 30 1.0 0.69 (0.16, 2.91) 0.92 (0.24, 3.58)
Clopidogre 0.4357
No 401 1.0 1.22 (0.75, 1.99) 2.37 (1.55, 3.61)
Yes 397 1.0 1.97 (1.14, 3.41) 3.04 (1.77, 5.20)
Aspirin 0.4040
No 191 1.0 0.98 (0.47, 2.05) 1.93 (1.08, 3.46)
Yes 607 1.0 1.73 (1.14, 2.62) 2.85 (1.90, 4.28)
Metoprolol 0.8271
No 236 1.0 1.30 (0.72, 2.35) 1.98 (1.17, 3.35)
Yes 562 1.0 1.53 (0.97, 2.41) 2.59 (1.68, 4.00)
ACEI/ARBs 0.3793
No 371 1.0 1.33 (0.83, 2.14) 2.21 (1.48, 3.31)
Yes 427 1.0 1.98 (1.13, 3.47) 2.19 (1.19, 4.03)
Statin 0.2013
No 242 1.0 1.25 (0.73, 2.15) 1.68 (1.04, 2.72)
Yes 556 1.0 1.67 (1.03, 2.71) 3.08 (1.94, 4.86)
PTCA/PCI 0.2614
No 313 1.0 1.19 (0.71, 1.99) 1.73 (1.10, 2.74)
Yes 485 1.0 1.69 (1.02, 2.80) 3.08 (1.89, 5.02)
Gender 0.7209
Female 294 1.0 1.37 (0.76, 2.47) 2.82 (1.65, 4.83)
Male 504 1.0 1.57 (1.00, 2.47) 2.52 (1.65, 3.86)
Race 0.5510
White 518 1.0 1.43 (0.88, 2.34) 2.84 (1.85, 4.38)
Black 46 1.0 2.63 (0.66, 10.56) 6.29 (1.49, 26.52)
Other 234 1.0 1.26 (0.70, 2.25) 1.99 (1.14, 3.48)
ALT (U/L) 0.6194
< 35.81 393 1.0 1.35 (0.80, 2.28) 2.88 (1.80, 4.64)
≥ 35.81 405 1.0 1.57 (0.95, 2.58) 2.41 (1.51, 3.86)
AST (U/L) 0.8455
< 67.00 391 1.0 1.44 (0.82, 2.52) 2.84 (1.71, 4.73)
≥ 67.00 407 1.0 1.45 (0.91, 2.32) 0 2.40 (1.55, 3.72)
CK-peak (U/L) 0.9398
< 823.00 397 1.0 1.46 (0.88, 2.41) 2.56 (1.64, 4.01)
≥ 823.00 401 1.0 1.56 (0.93, 2.63) 2.81 (1.71, 4.62)
CK-MB-peak (U/L) 0.9731
< 48.00 398 1.0 1.54 (0.91, 2.60) 2.69 (1.68, 4.30)
≥ 48.00 399 1.0 1.45 (0.89, 2.38) 2.66 (1.66, 4.28)
Glucose (mg/dL) 0.7956
< 148.00 395 1.0 1.53 (0.89, 2.61) 3.02 (1.85, 4.93)
≥ 148.00 403 1.0 1.45 (0.89, 2.36) 2.35 (1.50, 3.70)
PT (s) 0.2151
< 13.70 388 1.0 1.96 (1.18, 3.27) 2.82 (1.67, 4.78)
≥ 13.70 410 1.0 1.03 (0.62, 1.71) 2.00 (1.28, 3.13)
Hemoglobin (g/dL) 0.7119
< 12.40 394 1.0 1.20 (0.71, 2.03) 2.14 (1.34, 3.41)
≥ 12.40 404 1.0 1.62 (0.98, 2.66) 2.47 (1.47, 4.15)
RDW (%) 0.4510
< 13.80 394 1.0 1.37 (0.77, 2.42) 2.84 (1.65, 4.88)
≥ 13.80 404 1.0 1.55 (0.97, 2.47) 2.22 (1.45, 3.39)
Creatinine (mEq/L) 0.6118
< 1.10 303 1.0 1.76 (0.91, 3.42) 3.61 (1.91, 6.84)
≥ 1.10 399 1.0 1.69 (1.05, 2.73) 2.58 (1.66, 4.02)
BUN (mg/dL) 0.1007
< 22.00 370 1.0 2.26 (1.21, 4.21) 3.86 (2.07, 7.20)
≥ 22.00 414 1.0 1.11 (0.70, 1.75) 1.84 (1.23, 2.77)
WBC (109/L) 0.3940
< 12.00 383 1.0 1.38 (0.77, 2.46) 3.13 (1.85, 5.29)
≥ 12.00 401 1.0 1.40 (0.85, 2.31) 2.10 (1.32, 3.35)
Potassium (mmol/L) 0.5270
< 4.20 388 1.0 1.22 (0.71, 2.08) 2.43 (1.48, 3.98)
≥ 4.20 410 1.0 1.83 (1.13, 2.97) 2.90 (1.85, 4.54)
Sodium (mmol/L) 0.8463
< 139.00 384 1.0 1.64 (0.97, 2.78) 2.91 (1.77, 4.78)
≥ 139.00 414 1.0 1.35 (0.82, 2.24) 2.46 (1.57, 3.85)
Platelet (109/L) 0.9992
< 241.00 399 1.0 1.50 (0.90, 2.49) 2.68 (1.70, 4.21)
≥ 241.00 399 1.0 1.51 (0.91, 2.52) 2.62 (1.61, 4.29)
Age (years) 0.0469
< 70.00 394 1.0 1.26 (0.68, 2.32) 3.42 (1.99, 5.88)
≥ 70.00 404 1.0 1.58 (1.01, 2.47) 2.05 (1.35, 3.12)
Heart rate (beats/minute) 0.0023
< 101.00 385 1.0 2.61 (1.43, 4.77) 5.12 (2.89, 9.07)
≥ 101.00 413 1.0 0.92 (0.59, 1.45) 1.51 (1.00, 2.28)
Respiratory rate (beats/minute) 0.8764
< 26.00 368 1.0 1.44 (0.80, 2.58) 2.83 (1.65, 4.83)
≥ 26.00 430 1.0 1.54 (0.98, 2.44) 2.56 (1.67, 3.90)
MBP (mmHg) 0.4178
< 57.00 371 1.0 1.16 (0.70, 1.92) 2.23 (1.43, 3.46)
≥ 57.00 427 1.0 1.87 (1.12, 3.13) 2.79 (1.68, 4.66)
Weight (kg) 0.6674
< 78.00 392 1.0 1.76 (1.04, 2.97) 3.01 (1.84, 4.91)
≥ 78.00 406 1.0 1.26 (0.76, 2.08) 2.32 (1.46, 3.69)
ICU LOS (day) 0.0002
< 3.69 399 1.0 1.28 (0.73, 2.25) 4.33 (2.66, 7.03)
≥ 3.69 399 1.0 1.40 (0.87, 2.27) 1.59 (1.01, 2.52)
SAPS II 0.0010
< 31.00 247 1.0 8.90 (2.01, 39.44) 19.22 (4.30, 85.91)
≥ 31.00, < 45 278 1.0 1.10 (0.58, 2.08) 1.33 (0.72, 2.45)
≥ 45 273 1.0 0.96 (0.60, 1.54) 1.44 (0.95, 2.18)
SOFA 0.0605
< 3.00 247 1.0 2.17 (0.92, 5.11) 5.29 (2.19, 12.78)
≥ 3.00, < 6.00 236 1.0 1.91 (0.96, 3.82) 1.75 (0.88, 3.50)
≥ 6.00 315 1.0 0.95 (0.58, 1.54) 1.53 (1.00, 2.33)
Urine output (ml/24 h) 0.2991
< 1805.00 399 1.0 1.26 (0.79, 2.01) 1.84 (1.21, 2.82)
≥ 1805.00 399 1.0 1.54 (0.87, 2.73) 3.20 (1.86, 5.50)

HR hazard ratio, CI confidence interval, AF atrial fibrillation, CHF chronic heart failure, CDK chronic kidney disease, COPD chronic obstructive pulmonary disease, CAD coronary artery disease, prior MI prior myocardial infarction, ACEI/ARBs angiotensin-converting enzyme inhibitor/angiotensin receptor blockers, PTCA/PCI percutaneous transluminal coronary angioplasty/percutaneous coronary intervention, ALT alanine aminotransferase, AST aspartate aminotransferase, CK creatine kinase, CK-MB MB isoenzyme of creatine kinase, PT prothrombin time, RDW red cell distribution width, BUN blood urea nitrogen, WBC white blood cell, MBP mean blood pressure, ICU LOS length of ICU stay, SAPS II simplified acute physiology score II, SOFA sequential organ failure assessment score